|
Hindustan Bio Sciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
7.47 Cr.
|
P/BV
|
8.26
|
Book Value (Rs.)
|
0.88
|
|
52 Week High/Low (Rs.)
|
13/7
|
FV/ML
|
2/1
|
P/E(X)
|
74.24
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.10
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.10 | 0.06 | -0.04 | -0.50 | -0.92 |
| Diluted EPS (Rs.) | 0.10 | 0.06 | -0.04 | -0.50 | -0.92 |
| Cash EPS (Rs.) | 0.09 | 0.06 | -0.03 | -0.50 | -0.90 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 0.88 | 0.78 | 0.72 | 0.76 | 1.27 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 0.88 | 0.78 | 0.72 | 0.76 | 1.27 |
| Revenue From Operations / Share (Rs.) | 0.79 | 1.03 | 0.89 | 0.42 | 1.01 |
| PBDIT / Share (Rs.) | 0.09 | 0.06 | -0.02 | -0.49 | -0.91 |
| PBIT / Share (Rs.) | 0.09 | 0.05 | -0.03 | -0.49 | -0.92 |
| PBT / Share (Rs.) | 0.09 | 0.05 | -0.03 | -0.50 | -0.93 |
| Net Profit / Share (Rs.) | 0.09 | 0.05 | -0.03 | -0.50 | -0.91 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 12.27 | 6.06 | -3.05 | -117.53 | -91.13 |
| PBIT Margin (%) | 12.24 | 5.41 | -3.67 | -118.32 | -91.91 |
| PBT Margin (%) | 12.07 | 5.06 | -4.11 | -119.47 | -92.57 |
| Net Profit Margin (%) | 12.38 | 5.47 | -4.38 | -120.18 | -91.07 |
| Return on Networth / Equity (%) | 11.12 | 7.16 | -5.41 | -65.75 | -72.04 |
| Return on Capital Employeed (%) | 2.92 | 1.69 | -1.81 | -27.41 | -46.54 |
| Return On Assets (%) | 2.94 | 1.70 | -1.23 | -17.39 | -26.95 |
| Long Term Debt / Equity (X) | 2.77 | 3.18 | 1.50 | 1.36 | 0.56 |
| Total Debt / Equity (X) | 2.77 | 3.18 | 3.29 | 2.75 | 1.42 |
| Asset Turnover Ratio (%) | 0.23 | 0.31 | 0.29 | 0.13 | 0.22 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 73.31 | 69.04 | 0.60 | 0.48 | 0.72 |
| Quick Ratio (X) | 73.31 | 69.04 | 0.60 | 0.48 | 0.72 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 71.29 | 17.33 | -6.88 | -101.64 | -136.86 |
| Interest Coverage Ratio (Post Tax) (%) | 72.93 | 16.63 | -8.87 | -102.94 | -135.78 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 9.65 | 9.95 | 7.81 | 6.48 | 4.92 |
| EV / Net Operating Revenue (X) | 11.86 | 9.45 | 8.47 | 15.06 | 4.77 |
| EV / EBITDA (X) | 96.69 | 155.82 | -277.11 | -12.81 | -5.23 |
| MarketCap / Net Operating Revenue (X) | 8.80 | 7.06 | 5.91 | 10.05 | 2.98 |
| Price / BV (X) | 7.91 | 9.24 | 7.31 | 5.50 | 2.36 |
| Price / Net Operating Revenue (X) | 8.80 | 7.06 | 5.91 | 10.05 | 2.98 |
| EarningsYield | 0.01 | 0.01 | -0.01 | -0.11 | -0.30 |
